BTIG Research Reaffirms “Buy” Rating for Astrana Health (NASDAQ:ASTH)

Astrana Health (NASDAQ:ASTH)‘s stock had its “buy” rating reissued by BTIG Research in a report issued on Tuesday,Benzinga reports. They presently have a $50.00 target price on the stock. BTIG Research’s price target suggests a potential upside of 32.42% from the stock’s current price.

A number of other equities analysts have also recently weighed in on the stock. Truist Financial upped their price objective on shares of Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. Weiss Ratings upgraded shares of Astrana Health from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Barclays upgraded shares of Astrana Health from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $37.00 to $50.00 in a research report on Tuesday, May 26th. TD Cowen upped their price objective on shares of Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Finally, Robert W. Baird set a $45.00 price objective on shares of Astrana Health in a research report on Friday, May 8th. Seven investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $45.00.

Astrana Health Stock Performance

ASTH opened at $37.76 on Tuesday. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 1.35. The firm has a fifty day moving average price of $32.36 and a 200 day moving average price of $26.52. Astrana Health has a 1 year low of $18.08 and a 1 year high of $39.93. The stock has a market cap of $2.10 billion, a P/E ratio of 61.90 and a beta of 0.98.

Astrana Health (NASDAQ:ASTH) last posted its earnings results on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.45. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The firm had revenue of $965.10 million during the quarter, compared to analysts’ expectations of $949.21 million. During the same period in the previous year, the business posted $0.42 EPS. The business’s revenue was up 55.6% compared to the same quarter last year. Equities research analysts anticipate that Astrana Health will post 1.25 earnings per share for the current year.

Institutional Investors Weigh In On Astrana Health

Hedge funds have recently modified their holdings of the company. Signaturefd LLC grew its holdings in shares of Astrana Health by 57.9% in the fourth quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after purchasing an additional 388 shares during the period. GAMMA Investing LLC boosted its stake in Astrana Health by 144.7% during the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after buying an additional 871 shares during the period. Strs Ohio purchased a new position in Astrana Health during the fourth quarter worth about $40,000. Tower Research Capital LLC TRC boosted its stake in Astrana Health by 323.3% during the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after buying an additional 3,517 shares during the period. Finally, State of Wyoming purchased a new position in Astrana Health during the second quarter worth about $132,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.